316 related articles for article (PubMed ID: 29923305)
1. Efficacy of a novel herbal formulation for weight loss demonstrated in a 16-week randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults.
Dixit K; Kamath DV; Alluri KV; Davis BA
Diabetes Obes Metab; 2018 Nov; 20(11):2633-2641. PubMed ID: 29923305
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study.
Sengupta K; Mishra AT; Rao MK; Sarma KV; Krishnaraju AV; Trimurtulu G
Lipids Health Dis; 2012 Sep; 11():122. PubMed ID: 22995673
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects.
Kudiganti V; Kodur RR; Kodur SR; Halemane M; Deep DK
Lipids Health Dis; 2016 Aug; 15(1):136. PubMed ID: 27558585
[TBL] [Abstract][Full Text] [Related]
4. Combined extracts of Moringa oleifera, Murraya koeingii leaves, and Curcuma longa rhizome increases energy expenditure and controls obesity in high-fat diet-fed rats.
Kundimi S; Kavungala KC; Sinha S; Tayi VNR; Kundurthi NR; Golakoti T; Davis B; Sengupta K
Lipids Health Dis; 2020 Aug; 19(1):198. PubMed ID: 32859217
[TBL] [Abstract][Full Text] [Related]
5. Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.
Uebelhack R; Bongartz U; Seibt S; Bothe G; Chong PW; De Costa P; Wszelaki N
J Obes; 2019; 2019():3412952. PubMed ID: 30863632
[TBL] [Abstract][Full Text] [Related]
6. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a novel herbal formulation for weight management.
Stern JS; Peerson J; Mishra AT; Sadasiva Rao MV; Rajeswari KP
Obesity (Silver Spring); 2013 May; 21(5):921-7. PubMed ID: 23784895
[TBL] [Abstract][Full Text] [Related]
8. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Wadden TA; Bailey TS; Billings LK; Davies M; Frias JP; Koroleva A; Lingvay I; O'Neil PM; Rubino DM; Skovgaard D; Wallenstein SOR; Garvey WT;
JAMA; 2021 Apr; 325(14):1403-1413. PubMed ID: 33625476
[TBL] [Abstract][Full Text] [Related]
9. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.
Ngondi JL; Etoundi BC; Nyangono CB; Mbofung CM; Oben JE
Lipids Health Dis; 2009 Mar; 8():7. PubMed ID: 19254366
[TBL] [Abstract][Full Text] [Related]
10. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
11. Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
Cho YG; Jung JH; Kang JH; Kwon JS; Yu SP; Baik TG
BMC Complement Altern Med; 2017 Jul; 17(1):375. PubMed ID: 28754119
[TBL] [Abstract][Full Text] [Related]
12. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome.
Oben J; Kuate D; Agbor G; Momo C; Talla X
Lipids Health Dis; 2006 Sep; 5():24. PubMed ID: 16948861
[TBL] [Abstract][Full Text] [Related]
13. IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.
Chong PW; Beah ZM; Grube B; Riede L
Phytother Res; 2014 Oct; 28(10):1520-6. PubMed ID: 24797657
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of an herbal formulation for weight management.
Stern JS; Peerson J; Mishra AT; Mathukumalli VS; Konda PR
J Med Food; 2013 Jun; 16(6):529-37. PubMed ID: 23767862
[TBL] [Abstract][Full Text] [Related]
15. A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.
Grube B; Chong PW; Lau KZ; Orzechowski HD
Obesity (Silver Spring); 2013 Jan; 21(1):58-64. PubMed ID: 23505169
[TBL] [Abstract][Full Text] [Related]
16. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
Rubino D; Abrahamsson N; Davies M; Hesse D; Greenway FL; Jensen C; Lingvay I; Mosenzon O; Rosenstock J; Rubio MA; Rudofsky G; Tadayon S; Wadden TA; Dicker D;
JAMA; 2021 Apr; 325(14):1414-1425. PubMed ID: 33755728
[TBL] [Abstract][Full Text] [Related]
17. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
[TBL] [Abstract][Full Text] [Related]
18. Safety and toxicological evaluation of a novel anti-obesity formulation LI85008F in animals.
Krishnaraju AV; Sundararaju D; Srinivas P; Rao CV; Sengupta K; Trimurtulu G
Toxicol Mech Methods; 2010 Feb; 20(2):59-68. PubMed ID: 20158386
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide for weight loss in obese adults: a randomized controlled trial.
Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
[TBL] [Abstract][Full Text] [Related]
20. Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study.
Grube B; Chong PW; Alt F; Uebelhack R
J Obes; 2015; 2015():953138. PubMed ID: 26435849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
